TW
Insider buying
Thane Wettig bought $20K of Kyntra Bio, Inc. (KYNB) stock
Thane Wettig, CEO of Kyntra Bio, Inc. (KYNB), bought 2,800 shares of KYNB stock worth $20K, per an SEC Form 4 filed May 18, 2026.
It was an open-market purchase.
The trade happened on May 14, 2026, 4 days before it was made public.
KYNB has moved -15.0% since the trade date, from $7.01 to $5.96 (Oct 6, 2026 close).
- Traded
- May 14, 2026
- Disclosed
- May 18, 2026
- Filing delay
- 4 days
- Price since
- -15.0%
- Role
- CEO
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.